<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">Diabetic neuropathy</z:e> (DN) has been associated with <z:e sem="disease" ids="C0043352" disease_type="Disease or Syndrome" abbrv="">oral dryness</z:e>, <z:e sem="disease" ids="C0080233" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">tooth loss</z:e> and an increased risk for foot ulceration, but the association between periodontal problems and DN has not been fully elucidated </plain></SENT>
<SENT sid="1" pm="."><plain>This study investigated whether the risk for neuropathic foot ulceration (DM-NFUR) was associated with <z:e sem="disease" ids="C0031090" disease_type="Disease or Syndrome" abbrv="">periodontal disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: This cross-sectional study examined 122 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>; findings were compared with results for presence of DM-NFUR </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> severity was classified as none/mild (NM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>), moderate/severe (MS-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) and <z:e sem="disease" ids="C0026644" disease_type="Disease or Syndrome" abbrv="">edentulous</z:e> (E) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: NM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> was found in 40.2% patients; MS-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>, in 32.0%; and 27.8% were <z:e sem="disease" ids="C0026644" disease_type="Disease or Syndrome" abbrv="">edentulous</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>DM-NFUR was detected in 18.4% of the patients in the NM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> group, in 68.2% in the MS-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> group, and in 61.8% of completely <z:e sem="disease" ids="C0026644" disease_type="Disease or Syndrome" abbrv="">edentulous</z:e> individuals </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> was significantly correlated with DM-NFUR (p&lt;or=0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>After adjustment for sex, age, <z:mp ids='MP_0002055'>diabetes</z:mp> duration, dental health care and education, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and <z:e sem="disease" ids="C0949179" disease_type="Disease or Syndrome" abbrv="">edentulism</z:e> were independently associated with DM-NFUR (odds ratio(adjusted); 6.6; 95% CI 2.3-18.8; p&lt;or=0.001, and odds ratio(adjusted) 4.9; 95% CI 1.6-15.3; p&lt;or=0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Patients with DM-NFUR have substantially more MS-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and <z:e sem="disease" ids="C0949179" disease_type="Disease or Syndrome" abbrv="">edentulism</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Further studies should evaluate whether <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> is a risk factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> </plain></SENT>
</text></document>